Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic Migraine

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 18, 2019

Primary Completion Date

February 18, 2020

Study Completion Date

February 18, 2020

Conditions
Chronic Migraine
Interventions
DEVICE

Nerivio

The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. The treatment is self-administered and controlled by a smartphone application.

Trial Locations (2)

12540

Health Quest Medical Practice, PC, Lagrangeville

4428164

Meir Medical Center, Kfar Saba

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theranica

INDUSTRY

NCT04161807 - Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic Migraine | Biotech Hunter | Biotech Hunter